Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Phase 2 Completed 20 enrolled Shin Poong Pharmaceutical Co. Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This study is a multi-center, single-arm, open-label, pilot clinical trial to explore efficacy and safety of Pyramax in mild to moderate COVID-19 patients

Timeline

Start: 2022-07-24
Primary completion: 2022-09-06
Completion: 2022-11-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	pyronaridine-artesunate	Other / unclassified	—	—

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Summary

Timeline

Drugs

Indications